Part II - First, Do No Harm: The Medical Ethics Crisis Beneath Transgender Ideology

Feb 17

Introduction: When Medicine Becomes Ideology

The medical profession was once a bastion of trust, rooted in the Hippocratic ideal: “First, do no harm.” But in recent years, that foundation has been destabilized by a sociopolitical current that demands the immediate affirmation of subjective gender identities—even at the expense of rigorous clinical assessment, long-term data, and the principles of ethical practice.

This shift—driven by a potent mixture of ideology, fear of reprisal, and cultural conformity—has given rise to a medical ethics crisis. From the overprescription of hormones and surgeries to the silencing of dissenting doctors, transgender medicine has become a flashpoint where ideology supplants evidence and the vulnerable pay the price.

I. Informed Consent or Ideological Consent?

Informed consent requires full disclosure of risks, alternatives, and long-term outcomes. But studies show that young patients are being transitioned medically with minimal psychological evaluation or comprehensive discussion of consequences.

In a 2022 review by Cass (UK), over 80% of youth referred to gender clinics had comorbid mental health conditions—including depression, autism spectrum disorders, and trauma—yet these were often overlooked in the rush to affirm gender identity (Cass Review, 2022).
The average number of clinical sessions before initiating puberty blockers at the now-closed Tavistock clinic in the UK was just one or two (Biggs, 2020).
According to the Journal of Clinical Endocrinology and Metabolism, cross-sex hormone use in adolescents is associated with decreased fertility and irreversible physical changes (Hembree et al., 2017).

The Endocrine Society, which supports affirmation care, acknowledges that no randomized controlled trials exist to support the long-term efficacy and safety of puberty blockers for gender dysphoria (Hembree et al., 2017).

This means patients are often consenting to experimental treatments without a reliable evidence base—a direct violation of the ethical requirement for informed consent.

II. The Suppression of Dissent: Silencing the Medical Conscience

Ethical medicine requires freedom of inquiry. Yet medical professionals who question gender-affirming protocols face significant risk:

In 2022, Dr. Erica Anderson—a transgender psychologist and former president of the USPATH board—warned against the “sloppy, dangerous” overuse of affirmation-only models, especially for adolescents. She reported backlash and censorship after going public (Anderson, 2022).
A survey published by the BMJ found that clinicians in gender identity clinics felt pressure to “affirm” without asking questions, for fear of professional consequences (Carlile, 2020).
In Finland and Sweden—two of the most liberal European nations—health authorities have reversed their approach, now recommending psychotherapy as a first-line treatment and warning against automatic use of medical interventions (Finnish Health Authority, 2020; Swedish National Board of Health, 2022).

When doctors must choose between professional survival and honest care, ethics have already collapsed.

III. The Forgotten Patient: Detransitioners and the Ethics of Regret

One of the most alarming aspects of this crisis is the growing number of detransitioners—individuals who underwent medical transition and later regretted it. These cases highlight serious ethical failures:

A 2021 study in Archives of Sexual Behavior found that 10% of surveyed transgender individuals had detransitioned, primarily due to realizing that gender transition didn’t resolve underlying issues (Littman, 2021).
In a 2022 report from the Society for Evidence-Based Gender Medicine (SEGM), detransitioners cited lack of proper evaluation, pressure to conform, and dismissal of mental health issues as primary causes for regret (SEGM, 2022).
The popular online community r/detrans on Reddit now has over 50,000 members, many of whom share deeply personal stories of irreversible damage, infertility, and medical betrayal.

Yet major medical organizations remain silent on detransitioners, and very few longitudinal studies exist tracking long-term outcomes. Their silence reflects a system more invested in ideological purity than in understanding the full spectrum of patient experience.

IV. The Ethics of Non-Maleficence: Who Protects the Children?

Children represent a unique ethical category in medicine. Their vulnerability demands the highest level of caution. Yet transgender ideology encourages radical interventions with little longitudinal safety data:

The number of children referred to gender clinics in the UK rose by over 4,000% between 2009 and 2019 (Cass Review, 2022).
A 2020 study in the Journal of Adolescent Health warned that long-term effects of puberty blockers on cognition and bone health are still unknown, with some evidence suggesting lasting harm (Klink et al., 2015).
According to the American College of Pediatricians, “There is no case in which encouraging a child to reject their biological sex has been proven to reduce suicide in the long term” (ACPeds, 2018).

Moreover, the suicide narrative so often used to justify fast-tracking transition is based on selective and sometimes misleading data. A widely cited 2015 survey by the National Center for Transgender Equality found that 40% of trans individuals had attempted suicide, but failed to distinguish between pre- and post-transition causes (James et al., 2016).

To scare parents into irreversible decisions with cherry-picked statistics is not ethics—it is emotional manipulation.

Corollary Thought: The Return of the Physician’s Soul

Medicine must return to its roots—not as a vehicle for ideological compliance, but as a disciplined art of healing, anchored in evidence and humility. When young people present with gender distress, the ethical response is not to rush them into lifelong medicalization, but to slow down, listen, explore, and do no harm.

We owe our patients honesty. We owe our profession integrity. And we owe our children the protection of truth.

Until we recover these principles, the crisis will continue—and with it, the long shadow of irreversible regret.

References (APA style)

Anderson, E. (2022). Trans clinician speaks out. Washington Post Interview.
Biggs, M. (2020). The Tavistock’s Experiment with Puberty Blockers. Oxford University Department of Sociology.
Carlile, A. (2020). The experiences of professionals who work with children and young people experiencing gender distress. BMJ Paediatrics Open, 4(1).
Cass, H. (2022). Independent Review of Gender Identity Services for Children and Young People: Interim Report. NHS England.
Finnish Health Authority. (2020). Recommendation: Medical treatment methods for dysphoria are not evidence-based.
Hembree, W. C., et al. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons. Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903.
James, S. E., et al. (2016). The Report of the 2015 U.S. Transgender Survey. National Center for Transgender Equality.
Klink, D., Caris, M., Heijboer, A., van Trotsenburg, M., & Rotteveel, J. (2015). Bone mass in young adulthood after GnRH analog treatment. Journal of Clinical Endocrinology & Metabolism, 100(5), E270–E275.
Littman, L. (2021). Individuals treated for gender dysphoria who subsequently detransitioned: Survey results. Archives of Sexual Behavior, 50(8), 3353–3369.
Society for Evidence-Based Gender Medicine (SEGM). (2022). Detransitioner Survey and Testimonies.
Swedish National Board of Health and Welfare. (2022). New guidelines for gender dysphoria: Medical transition should be rare for minors.

The Abuse Log